Moderna (MRNA) Assets Average (2019 - 2025)
Moderna (MRNA) has disclosed Assets Average for 7 consecutive years, with $12.2 billion as the latest value for Q4 2025.
- Quarterly Assets Average fell 18.27% to $12.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 billion through Dec 2025, down 18.27% year-over-year, with the annual reading at $13.2 billion for FY2025, 18.69% down from the prior year.
- Assets Average for Q4 2025 was $12.2 billion at Moderna, up from $12.1 billion in the prior quarter.
- The five-year high for Assets Average was $26.8 billion in Q2 2022, with the low at $10.0 billion in Q1 2021.
- Average Assets Average over 5 years is $18.6 billion, with a median of $18.1 billion recorded in 2021.
- The sharpest move saw Assets Average soared 447.75% in 2021, then dropped 29.67% in 2024.
- Over 5 years, Assets Average stood at $22.8 billion in 2021, then increased by 13.87% to $26.0 billion in 2022, then dropped by 27.04% to $18.9 billion in 2023, then dropped by 20.94% to $15.0 billion in 2024, then decreased by 18.27% to $12.2 billion in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $12.2 billion, $12.1 billion, and $12.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.